Open AccessPARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Author(s) -
Fengping Shao,
Yaoyun Duan,
Yunhe Zhao,
Yinguang Li,
Jun Liu,
Cai Zhang,
Shanyang He
Publication year - 2021
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.202724
Subject(s) - ovarian cancer , brca mutation , oncology , breast cancer , medicine , meta analysis , poly adp ribose polymerase , parp inhibitor , olaparib , cancer , cancer research , biology , genetics , polymerase , gene
To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom